NYSE:BME

BlackRock Health Sciences Trust Stock Forecast, Price & News

$47.98
-0.10 (-0.21 %)
(As of 06/15/2021 04:54 PM ET)
Add
Compare
Today's Range
$47.80
$48.23
50-Day Range
$46.22
$49.63
52-Week Range
$40.03
$50.94
Volume27,001 shs
Average Volume32,812 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.06%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BME News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.


About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.48 out of 5 stars

Finance Sector

1677th out of 1,976 stocks

Closed-End Fund - Equity Industry

6th out of 7 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











BlackRock Health Sciences Trust (NYSE:BME) Frequently Asked Questions

Is BlackRock Health Sciences Trust a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BlackRock Health Sciences Trust in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BlackRock Health Sciences Trust stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BME, but not buy additional shares or sell existing shares.
View analyst ratings for BlackRock Health Sciences Trust
or view top-rated stocks.

What stocks does MarketBeat like better than BlackRock Health Sciences Trust?

Wall Street analysts have given BlackRock Health Sciences Trust a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BlackRock Health Sciences Trust wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 3,700 shares, a decrease of 33.9% from the May 13th total of 5,600 shares. Based on an average daily trading volume, of 30,100 shares, the days-to-cover ratio is presently 0.1 days.
View BlackRock Health Sciences Trust's Short Interest
.

How has BlackRock Health Sciences Trust's stock price been impacted by COVID-19 (Coronavirus)?

BlackRock Health Sciences Trust's stock was trading at $37.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BME stock has increased by 28.9% and is now trading at $48.00.
View which stocks have been most impacted by COVID-19
.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust declared a monthly dividend on Tuesday, June 1st. Stockholders of record on Tuesday, June 15th will be given a dividend of $0.20 per share on Wednesday, June 30th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 5.00%. The ex-dividend date of this dividend is Monday, June 14th.
View BlackRock Health Sciences Trust's dividend history
.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust pays an annual dividend of $2.40 per share and currently has a dividend yield of 0.06%.
View BlackRock Health Sciences Trust's dividend history.

Who are BlackRock Health Sciences Trust's key executives?

BlackRock Health Sciences Trust's management team includes the following people:
  • Mr. Charles Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer (Age 54)
  • Mr. Thomas P. Callan C.F.A., CFA, Portfolio Mang.
  • Mr. Kyle G. McClements CFA, Portfolio Mang.
  • Dr. Erin Xie, Portfolio Mang. (Age 53)
  • Mr. Christopher M. Accettella, Portfolio Mang.
  • Mr. Jeffrey Gene Lee, Portfolio Mang.
  • Dr. Xiang Liu Ph.D., Portfolio Mang.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust CEO Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among BlackRock Health Sciences Trust's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of BlackRock Health Sciences Trust's key competitors?

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and The Procter & Gamble (PG).

What is BlackRock Health Sciences Trust's stock symbol?

BlackRock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by a number of retail and institutional investors. Top institutional investors include Morgan Stanley (0.00%), Ameriprise Financial Inc. (0.00%), Ahrens Investment Partners LLC (0.00%), Cambridge Investment Research Advisors Inc. (0.00%), HighTower Advisors LLC (0.00%) and Commonwealth Equity Services LLC (0.00%).
View institutional ownership trends for BlackRock Health Sciences Trust
.

Which major investors are selling BlackRock Health Sciences Trust stock?

BME stock was sold by a variety of institutional investors in the last quarter, including Ahrens Investment Partners LLC, Kestra Advisory Services LLC, Diversified LLC, Janney Montgomery Scott LLC, HighTower Advisors LLC, and Arete Wealth Advisors LLC.
View insider buying and selling activity for BlackRock Health Sciences Trust
or view top insider-selling stocks.

Which major investors are buying BlackRock Health Sciences Trust stock?

BME stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Ameriprise Financial Inc., Wolverine Asset Management LLC, Stratos Wealth Partners LTD., Waterfront Wealth Inc., Tranquility Partners LLC, Stifel Financial Corp, and Busey Wealth Management.
View insider buying and selling activity for BlackRock Health Sciences Trust
or or view top insider-buying stocks.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlackRock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $48.00.

What is BlackRock Health Sciences Trust's official website?

The official website for BlackRock Health Sciences Trust is www2.blackrock.com.

Where are BlackRock Health Sciences Trust's headquarters?

BlackRock Health Sciences Trust is headquartered at 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States.

How can I contact BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.


This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.